Loading...

Parya Saberi, PharmD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Phone415-502-1000 ext. 17171
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Parya Saberi, PharmD, MAS, AAHIVP is an Associate Professor at the Center for AIDS Prevention Studies (CAPS) in the Department of Medicine at the University of California, San Francisco. Dr. Saberi is funded by the National Institute of Mental Health (NIMH) through an R34 and an R21 award, the National Institute of Nursing Research (NINR) through an R01 award, and the California HIV Research Program (CHRP) for Health Disparities. Her research includes assessing technology-based strategies such as mobile applications, video-conferencing tools, and text messaging to improve ART adherence and engagement in HIV care among youth living with HIV. She is also examining novel adherence assessment methods and an HIV pre-exposure prophylaxis (PrEP) tool for healthcare providers who are prescribing PrEP. Her other research involvement includes developing a technology-based tool for HIV prevention and treatment for the San Francisco Bay Area House Ball Community and Gay Families (PI: Dr. Emily Arnold). She is currently an expert consultant at the National Clinicians' Consultation Center's HIV Warmline, PEPline, and PrEPline (nccc.ucsf.edu).

    Collapse Research 
    Collapse Research Activities and Funding
    Improving the HIV PrEP Cascade using an Intervention for Healthcare Providers
    NIH R01NR017573Jul 1, 2020 - Jun 30, 2021
    Role: Principal Investigator
    Perceptions of Risks and Benefits of Participating in HIV Cure-related Research among Diverse Youth and Young Adults Living with HIV in the United States
    NIH R21MH122280Apr 1, 2020 - Mar 31, 2022
    Role: Principal Investigator
    A Mobile Health Application for Engagement in Care among Youth Living with HIV
    NIH R34MH114604Aug 15, 2017 - Jun 30, 2021
    Role: Principal Investigator
    Rx Pix: A Novel Way to Assess Antiretroviral Adherence with Pharmacy Refill Dates
    NIH R21MH108414Feb 19, 2016 - Dec 31, 2018
    Role: Principal Investigator
    Technology-based adaptive treatment strategies for antiretroviral adherence
    NIH K23MH097649Jun 15, 2012 - Apr 30, 2018
    Role: Principal Investigator
    Quality of Sleep in HIV-Infection: associations with treatment and adherence
    NIH F32MH086323Jul 1, 2009 - Jun 30, 2012
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. HIV Res Clin Pract. 2021 Mar 24; 1-17. Dubé K, Kanazawa J, Dee L, Taylor J, Campbell DM, Brown B, Johnson MO, Saberi P, Sauceda JA, Sugarman J, Peluso MJ. PMID: 33757411.
      View in: PubMed   Mentions:    Fields:    
    2. Time to Engage Young People in HIV Cure Research. AIDS Res Hum Retroviruses. 2021 Mar 07. PMID: 33677996.
      View in: PubMed   Mentions:    Fields:    
    3. HIV pre-exposure prophylaxis in the time of COVID-19: How a robust and responsive HIV PrEP intervention can avert loss of HIV prevention coverage during a global pandemic. J Acquir Immune Defic Syndr. 2021 Jan 29. Saberi P, Ming K, Hojilla JC, Scott HM, Neilands TB. PMID: 33534275.
      View in: PubMed   Mentions:    Fields:    
    4. Video-Counseling Intervention to Address HIV Care Engagement, Mental Health, and Substance Use Challenges: A Pilot Randomized Clinical Trial for Youth and Young Adults Living with HIV. Telemed Rep. 2021; 2(1):14-25. Saberi P, McCuistian C, Agnew E, Wootton AR, Legnitto Packard DA, Dawson-Rose C, Johnson MO, Gruber VA, Neilands TB. PMID: 33575683.
      View in: PubMed   Mentions:
    5. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review. AIDS Res Hum Retroviruses. 2020 Nov 11. Kanazawa JT, Saberi P, Sauceda JA, Dube K. PMID: 33176429.
      View in: PubMed   Mentions:    Fields:    
    6. "You can't have a PrEP program without a PrEP Coordinator": Implementation of a PrEP panel management intervention. PLoS One. 2020; 15(10):e0240745. Saberi P, Ming K, Scott H, Liu A, Steward W. PMID: 33064763.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    7. Re-examining the HIV 'functional cure' oxymoron: Time for precise terminology? J Virus Erad. 2020 Nov; 6(4):100017. Dubé K, Willenberg L, Dee L, Sylla L, Taylor J, Roebuck C, Palm D, Campbell D, Newton L, Patel H, Perry KE, Kanazawa J, Gerrard J, Brown B, Saberi P, Sauceda JA, Peluso MJ. PMID: 33251025.
      View in: PubMed   Mentions:
    8. Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2020 10 13; 222(10):1607-1611. Sauceda JA, Neilands TB, Lightfoot M, Saberi P. PMID: 32860499.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    9. We are family: designing and developing a mobile health application for the San Francisco bay area House Ball and Gay Family communities. Mhealth. 2020; 6:42. Saberi P, Berrean B, Milionis C, Wong JO, Arnold E. PMID: 33437838.
      View in: PubMed   Mentions:
    10. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options. AIDS Res Hum Retroviruses. 2020 12; 36(12):1054-1058. Dubé K, Campbell DM, Perry KE, Kanazawa JT, Saberi P, Sauceda JA, Poteat T, Evans D. PMID: 32829645.
      View in: PubMed   Mentions:    Fields:    
    11. Altruism: Scoping review of the literature and future directions for HIV cure-related research. J Virus Erad. 2020 Nov; 6(4):100008. Dubé K, Perry KE, Mathur K, Lo M, Javadi SS, Patel H, Concha-Garcia S, Taylor J, Kaytes A, Dee L, Campbell D, Kanazawa J, Smith D, Gianella S, Auerbach JD, Saberi P, Sauceda JA. PMID: 33294210.
      View in: PubMed   Mentions:
    12. Research in the Time of Coronavirus: Continuing Ongoing Studies in the Midst of the COVID-19 Pandemic. AIDS Behav. 2020 08; 24(8):2232-2235. Saberi P. PMID: 32303924.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    13. Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol. BMJ Open. 2020 07 14; 10(7):e040734. Ming K, Shrestha I, Vazquez A, Wendelborn J, Jimenez V, Lisha N, Neilands TB, Scott H, Liu A, Steward W, Johnson MO, Saberi P. PMID: 32665393.
      View in: PubMed   Mentions: 2     Fields:    
    14. Attitudes about community pharmacy access to HIV prevention medications in California. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):e179-e183. Koester KA, Saberi P, Fuller SM, Arnold EA, Steward WT. PMID: 32665097.
      View in: PubMed   Mentions:    Fields:    
    15. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey. AIDS Res Hum Retroviruses. 2020 07; 36(7):606-615. Saberi P, Eskaf S, Sauceda J, Evans D, Dubé K. PMID: 32368934.
      View in: PubMed   Mentions:    Fields:    
    16. On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know. J Gen Intern Med. 2020 Apr; 35(4):1285-1288. Saberi P, Scott HM. PMID: 31965523.
      View in: PubMed   Mentions:    Fields:    
    17. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence. AIDS Behav. 2020 Jan; 24(1):284-290. Saberi P, Chakravarty D, Ming K, Legnitto D, Gandhi M, Johnson MO, Neilands TB. PMID: 31758349.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2020 04; 36(4):324-348. Dubé K, Eskaf S, Evans D, Sauceda J, Saberi P, Brown B, Averitt D, Martel K, Meija M, Campbell D, Barr L, Kanazawa J, Perry K, Patel H, Luter S, Poteat T, Auerbach JD, Wohl DA. PMID: 31608651.
      View in: PubMed   Mentions: 5     Fields:    
    19. Overcoming Technological Challenges: Lessons Learned from a Telehealth Counseling Study. Telemed J E Health. 2020 Oct; 26(10):1278-1283. Wootton AR, McCuistian C, Legnitto Packard DA, Gruber VA, Saberi P. PMID: 31800368.
      View in: PubMed   Mentions: 3     Fields:    
    20. Telehealth and texting intervention to improve HIV care engagement, mental health and substance use outcomes in youth living with HIV: a pilot feasibility and acceptability study protocol. BMJ Open. 2019 07 16; 9(7):e028522. Wootton AR, Legnitto DA, Gruber VA, Dawson-Rose C, Neilands TB, Johnson MO, Saberi P. PMID: 31315868.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Food Insecurity and Unmet Needs Among Youth and Young Adults Living With HIV in the San Francisco Bay Area. J Adolesc Health. 2019 08; 65(2):262-266. Reeder C, Neilands TB, Palar K, Saberi P. PMID: 31196781.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective. AIDS Care. 2020 08; 32(8):931-939. Saberi P, Dawson Rose C, Wootton AR, Ming K, Legnitto D, Jeske M, Pollack LM, Johnson MO, Gruber VA, Neilands TB. PMID: 31132864.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. WYZ: a pilot study protocol for designing and developing a mobile health application for engagement in HIV care and medication adherence in youth and young adults living with HIV. BMJ Open. 2019 05 05; 9(5):e030473. Erguera XA, Johnson MO, Neilands TB, Ruel T, Berrean B, Thomas S, Saberi P. PMID: 31061063.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study. PLoS One. 2019; 14(1):e0210791. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. PMID: 30645641.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    25. The Association between Use of Online Social Networks to Find Sex Partners and Sexually Transmitted Infection Diagnosis among Young Men Who Have Sex with Men and Transgender Women Living with HIV. J Int Assoc Provid AIDS Care. 2019 Jan-Dec; 18:2325958219867324. Saberi P, Neilands TB, Lally MA, Hosek SG, Hightow-Weidman L. PMID: 31389285.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection. Integr Pharm Res Pract. 2018; 7:105-111. Olea A, Grochowski J, Luetkemeyer AF, Robb V, Saberi P. PMID: 30214893.
      View in: PubMed   Mentions:
    27. Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study. Patient Prefer Adherence. 2018; 12:1033-1042. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. PMID: 29950816.
      View in: PubMed   Mentions:
    28. What does it mean to be youth-friendly? Results from qualitative interviews with health care providers and clinic staff serving youth and young adults living with HIV. Adolesc Health Med Ther. 2018; 9:65-75. Saberi P, Ming K, Dawson-Rose C. PMID: 29731672.
      View in: PubMed   Mentions:
    29. An update on the Barriers to Adherence and a Definition of Self-Report Non-adherence Given Advancements in Antiretroviral Therapy (ART). AIDS Behav. 2018 03; 22(3):939-947. Sauceda JA, Neilands TB, Johnson MO, Saberi P. PMID: 28352983.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study. JMIR Form Res. 2018 Jan-Jun; 2(1). Saberi P, Berrean B, Thomas S, Gandhi M, Scott H. PMID: 30637375.
      View in: PubMed   Mentions:
    31. Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States. Clin Infect Dis. 2018 01 06; 66(2):213-219. Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M. PMID: 29020194.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    32. Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring. . 2017 12 01; 76(4):e101-e103. Saberi P, Neilands TB, Ming K, Johnson MO, Kuncze K, Koss CA, Gandhi M. PMID: 28657913.
      View in: PubMed   Mentions:
    33. Using Path Analysis to Evaluate the Healthcare Empowerment Model Among Persons Living with HIV for Antiretroviral Therapy Adherence. AIDS Patient Care STDS. 2016 11; 30(11):497-505. van den Berg JJ, Neilands TB, Johnson MO, Chen B, Saberi P. PMID: 27849372.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    34. Nonadherence as 4-day Antiretroviral Therapy Interruptions: Do Depression and Race/Ethnicity Matter as Much in the Modern Antiretroviral Therapy Era? AIDS Behav. 2016 11; 20(11):2624-2628. Sauceda JA, Johnson MO, Saberi P. PMID: 26767532.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    35. The Use of Mobile Health Applications Among Youth and Young Adults Living with HIV: Focus Group Findings. AIDS Patient Care STDS. 2016 06; 30(6):254-60. Saberi P, Siedle-Khan R, Sheon N, Lightfoot M. PMID: 27214751.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    36. Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial. Trials. 2016 Feb 06; 17:68. Lippman SA, Shade SB, Sumitani J, DeKadt J, Gilvydis JM, Ratlhagana MJ, Grignon J, Tumbo J, Gilmore H, Agnew E, Saberi P, Barnhart S, Steward WT. PMID: 26852237.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Need for improvements in clinical practice to retain patients in pre-antiretroviral therapy care: Data from rural clinics in North West Province, South Africa. AIDS Care. 2015; 27(10):1275-8. Gilvydis JM, Steward WT, Saberi P, Tumbo J, Sumitani J, Barnhart S, Lippman SA. PMID: 26278130.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Correlation of Internet Use for Health Care Engagement Purposes and HIV Clinical Outcomes Among HIV-Positive Individuals Using Online Social Media. J Health Commun. 2015; 20(9):1026-32. Saberi P, Johnson MO. PMID: 26120890.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    39. Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:177-85. Saberi P, Catz SL, Leyden WA, Stewart C, Ralston JD, Horberg MA, Grothaus L, Silverberg MJ. PMID: 25572829.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    40. Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS Patient Care STDS. 2015 Mar; 29(3):111-6. Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE. PMID: 25615029.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    41. Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence. AIDS Behav. 2015 Jan; 19(1):93-103. Saberi P, Mayer K, Vittinghoff E, Naar-King S, . PMID: 24879628.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    42. Moving toward a novel and comprehensive behavioral composite of engagement in HIV care. AIDS Care. 2015; 27(5):660-4. Saberi P, Johnson MO. PMID: 25471139.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Association between dog guardianship and HIV clinical outcomes. J Int Assoc Provid AIDS Care. 2014 Jul-Aug; 13(4):300-4. Saberi P, Neilands TB, Johnson MO. PMID: 25513022.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    44. Association between Dog Guardianship and HIV Clinical Outcomes. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2014 Jul 1; 13(4):300-304. Parya Saberi, Torsten B. Neilands, Mallory O. Johnson. .
      View in: Publisher Site   Mentions:
    45. Using online social media for recruitment of human immunodeficiency virus-positive participants: a cross-sectional survey. J Med Internet Res. 2014 May 01; 16(5):e117. Yuan P, Bare MG, Johnson MO, Saberi P. PMID: 24784982.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    46. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. Sevelius JM, Saberi P, Johnson MO. PMID: 24646419.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    47. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85. Cocohoba J, Dong BJ, Johnson MO, Saberi P. PMID: 24467531.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDS. 2013 Sep; 27(9):529-32. Saberi P, Yuan P, John M, Sheon N, Johnson MO. PMID: 23991691.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    49. Qualitative study of the quality of sleep in marginalized individuals living with HIV. Patient Prefer Adherence. 2013; 7:499-507. Saberi P, Comfort M, Sheon N, Johnson MO. PMID: 23807839.
      View in: PubMed   Mentions:
    50. Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med. 2013 Oct; 14(9):519-29. Saberi P, Phengrasamy T, Nguyen DP. PMID: 23590676.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    51. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012; 7(11):e50061. Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, Johnson MO. PMID: 23166819.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCellsPHPublic Health
    52. Pharmacists as providers of HIV pre-exposure prophylaxis. Int J Clin Pharm. 2012 Dec; 34(6):803-6. Bruno C, Saberi P. PMID: 23073703.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    53. Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health. 2012 Oct; 89(5):794-801. Saberi P, Caswell NH, Jamison R, Estes M, Tulsky JP. PMID: 22547327.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    54. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective. . 2012 Sep 01; 61(1):e3-6. Saberi P, Comfort M, Johnson MO. PMID: 22918127.
      View in: PubMed   Mentions:
    55. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. PMID: 22654510.
      View in: PubMed   Mentions:
    56. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. PMID: 22536064.
      View in: PubMed   Mentions:
    57. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011; 6(11):e27533. Saberi P, Johnson MO. PMID: 22140446.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    58. Medication adherence: tailoring the analysis to the data. AIDS Behav. 2011 Oct; 15(7):1447-53. Saberi P, Johnson MO, McCulloch CE, Vittinghoff E, Neilands TB. PMID: 21833689.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    59. Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS. 2011 Sep; 25(9):517-24. Saberi P, Neilands TB, Johnson MO. PMID: 21770763.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    60. An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature. J Int Assoc Physicians AIDS Care (Chic). 2011 Jul-Aug; 10(4):219-22. Bruno CB, Schapiro JM, Saberi P. PMID: 21518854.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy. 2011 Mar; 31(3):253-61. Saberi P, Ranatunga DK, Quesenberry CP, Silverberg MJ. PMID: 21361735.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    62. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care. 2010 Oct; 22(10):1189-94. Ma A, Chen DM, Chau FM, Saberi P. PMID: 20640958.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    63. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008 Jul; 20(6):741-5. Saberi P, Caswell N, Amodio-Groton M, Alpert P. PMID: 18576177.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    64. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. PMID: 18413688.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. A Rainforest Expedition with The Student Rainforest Fund. Journal of Herbal Pharmacotherapy. 2005 Jan 1; 5(3):103-105. June Riedlinger, Niamh Higgins, Parya Saberi. .
      View in: Publisher Site   Mentions:
    Parya's Networks
    Concepts (188)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (36)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑